HR 877 · 111th Congress 2009โ€“2011, ended

Patients First Act of 2009

Latest action · Feb 9, 2009 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 4, 2009
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Patients First Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act.

Requires the Secretary to issue guidelines implementing this Act to ensure that any research (including any clinical trial) supported under this Act: (1) is clearly consistent with the standards established in this Act, if conducted using human cells; (2) is prioritized in terms of potential for near-term clinical benefit in human patients; and (3) may take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

Requires the Secretary to: (1) report on peer reviewed stem cell research proposals that were not funded; and (2) study and submit recommendations to Congress on any structural changes to the C.W. Bill Young Cell Transplantation Program that would help to expand access to new and future stem cell therapeutic products.

Cosponsors 48

Members who signed on, in the order they did. Signatures ran from Feb 4, 2009 to Sep 22, 2010; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-ILDaniel LipinskiOriginalFeb 4, 2009
R-CODoug LambornFeb 10, 2009
R-WYCynthia M. LummisFeb 12, 2009
R-SCHenry E. Brown, Jr.Feb 12, 2009
R-OHJean SchmidtFeb 12, 2009
R-PAJoseph R. PittsFeb 12, 2009
R-GALynn A. WestmorelandFeb 12, 2009
R-TXPete OlsonFeb 12, 2009
R-MIPeter HoekstraFeb 12, 2009
R-MDRoscoe G. BartlettFeb 12, 2009
R-AZTrent FranksFeb 12, 2009
R-CADaniel E. LungrenMar 2, 2009
R-VAEric CantorMar 2, 2009
R-ARJohn BoozmanMar 2, 2009
R-INMark E. SouderMar 2, 2009

Withdrew 1 Anna G. Eshoo D-CA Apr 15, 2010

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Feb 4, 2009
Health Subcommittee
Referred Feb 9, 2009

Actions 3

Everything that happened, newest first.

  1. Feb 9, 2009Referred to the Subcommittee on Health.
  2. Feb 4, 2009Introduced in House
  3. Feb 4, 2009Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H2961J. Randy Forbes R-VAMar 4, 2009

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To intensify stem cell research showing evidence of substantial clinical benefit to patients, and for other purposes.
Short Titles as Introduced
Patients First Act of 2009

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Feb 4, 2009Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.